Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 2
1990 1
1991 1
1992 1
1995 1
1996 2
1997 4
1998 2
1999 3
2000 2
2001 2
2002 2
2003 3
2004 2
2005 5
2006 9
2007 7
2008 7
2009 12
2010 10
2011 23
2012 22
2013 29
2014 29
2015 28
2016 44
2017 56
2018 48
2019 62
2020 67
2021 63
2022 33
Text availability
Article attribute
Article type
Publication date

Search Results

518 results
Results by year
Filters applied: . Clear all
Page 1
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma.
Xiong J, Cui BW, Wang N, Dai YT, Zhang H, Wang CF, Zhong HJ, Cheng S, Ou-Yang BS, Hu Y, Zhang X, Xu B, Qian WB, Tao R, Yan F, Hu JD, Hou M, Ma XJ, Wang X, Liu YH, Zhu ZM, Huang XB, Liu L, Wu CY, Huang L, Shen YF, Huang RB, Xu JY, Wang C, Wu DP, Yu L, Li JF, Xu PP, Wang L, Huang JY, Chen SJ, Zhao WL. Xiong J, et al. Cancer Cell. 2020 Mar 16;37(3):403-419.e6. doi: 10.1016/j.ccell.2020.02.005. Cancer Cell. 2020. PMID: 32183952 Free article.
The entry of nanoparticles into solid tumours.
Sindhwani S, Syed AM, Ngai J, Kingston BR, Maiorino L, Rothschild J, MacMillan P, Zhang Y, Rajesh NU, Hoang T, Wu JLY, Wilhelm S, Zilman A, Gadde S, Sulaiman A, Ouyang B, Lin Z, Wang L, Egeblad M, Chan WCW. Sindhwani S, et al. Among authors: ouyang b. Nat Mater. 2020 May;19(5):566-575. doi: 10.1038/s41563-019-0566-2. Epub 2020 Jan 13. Nat Mater. 2020. PMID: 31932672
The dose threshold for nanoparticle tumour delivery.
Ouyang B, Poon W, Zhang YN, Lin ZP, Kingston BR, Tavares AJ, Zhang Y, Chen J, Valic MS, Syed AM, MacMillan P, Couture-Senécal J, Zheng G, Chan WCW. Ouyang B, et al. Nat Mater. 2020 Dec;19(12):1362-1371. doi: 10.1038/s41563-020-0755-z. Epub 2020 Aug 10. Nat Mater. 2020. PMID: 32778816
Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma.
Yan ZX, Li L, Wang W, OuYang BS, Cheng S, Wang L, Wu W, Xu PP, Muftuoglu M, Hao M, Yang S, Zhang MC, Zheng Z, Li J, Zhao WL. Yan ZX, et al. Among authors: ouyang bs. Clin Cancer Res. 2019 Dec 1;25(23):6995-7003. doi: 10.1158/1078-0432.CCR-19-0101. Epub 2019 Aug 23. Clin Cancer Res. 2019. PMID: 31444250 Clinical Trial.
A framework for designing delivery systems.
Poon W, Kingston BR, Ouyang B, Ngo W, Chan WCW. Poon W, et al. Among authors: ouyang b. Nat Nanotechnol. 2020 Oct;15(10):819-829. doi: 10.1038/s41565-020-0759-5. Epub 2020 Sep 7. Nat Nanotechnol. 2020. PMID: 32895522 Review.
Synthetic accessibility and stability rules of NASICONs.
Ouyang B, Wang J, He T, Bartel CJ, Huo H, Wang Y, Lacivita V, Kim H, Ceder G. Ouyang B, et al. Nat Commun. 2021 Oct 1;12(1):5752. doi: 10.1038/s41467-021-26006-3. Nat Commun. 2021. PMID: 34599170 Free PMC article.
518 results